Allogeneic "Off-the-Shelf" CAR T cells: Challenges and advances
{{output}}
Chimeric antigen receptor (CAR) T cell therapy has shown impressive clinical efficacy in B cell malignancies and multiple myeloma, leading to the approval of six CAR T cell products by the U.S. Food and Drug Administration (FDA) to date. However, broad applica... ...
